HCV RNA levels more than 10,000 IU/mL and less than 6,000,000 IU/mL at Screening
You may not be if
Gastrointestinal disorder or post-operative condition that could interfere with the absorption of the study drug.
Solid organ transplantation.
Significant cardiac disease or other significant co-morbidities that could interfere with study treatment.
Infection with hepatitis B virus (HBV)
Clareo Health | Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 8 Weeks in Subjects With Chronic Genotype 1 HCV and HIV-1 Co-infection
